AGA Gene Aspartylglucosaminuria Genetic Test
Welcome to DNA Labs UAE, a leading genetic laboratory offering comprehensive genetic testing services. In this blog, we will discuss the AGA Gene Aspartylglucosaminuria Genetic Test, including its components, cost, symptoms, diagnosis, and more.
Test Name: AGA Gene Aspartylglucosaminuria Genetic Test
Components:
- Price: 4400.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test Type: Metabolic Disorders
- Doctor: General Physician
- Test Department: Genetics
Pre Test Information
Before undergoing the AGA Gene Aspartylglucosaminuria NGS Genetic DNA Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session may be conducted to draw a pedigree chart of family members affected by Aspartylglucosaminuria.
Test Details
The AGA gene (Aspartylglucosaminuria) NGS genetic test is a diagnostic test that analyzes the AGA gene for mutations or variations associated with Aspartylglucosaminuria. Aspartylglucosaminuria is a rare genetic disorder characterized by the accumulation of a substance called aspartylglucosamine in the body. This condition is inherited in an autosomal recessive manner.
The NGS (Next-Generation Sequencing) technology used in this genetic test allows for the sequencing of the entire AGA gene, providing a comprehensive analysis of all the coding regions and intron-exon boundaries. By identifying specific mutations or variations in the AGA gene, this test can help confirm a diagnosis of Aspartylglucosaminuria in individuals suspected of having this condition.
The AGA gene NGS genetic test is typically performed on a blood or saliva sample, and the results are interpreted by a qualified geneticist or genetic counselor. A positive result indicating the presence of mutations or variations in the AGA gene confirms the diagnosis of Aspartylglucosaminuria, while a negative result suggests that the individual is unlikely to have this condition.
This genetic test is primarily used for diagnostic purposes and can be helpful in guiding treatment decisions and providing genetic counseling to affected individuals and their families. It may also be used for carrier testing in individuals with a family history of Aspartylglucosaminuria or in populations with a higher prevalence of this condition.
It is important to note that genetic testing should always be performed and interpreted in conjunction with a comprehensive clinical evaluation, considering the individual’s symptoms, family history, and other relevant factors. Genetic counseling is recommended before and after undergoing genetic testing to ensure a thorough understanding of the test results and their implications.
| Test Name | AGA Gene Aspartylglucosaminuria Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Metabolic Disorders |
| Doctor | General Physician |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for AGA Gene Aspartylglucosaminuria NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Aspartylglucosaminuria |
| Test Details |
AGA gene (Aspartylglucosaminuria) NGS genetic test is a diagnostic test that analyzes the AGA gene for mutations or variations associated with Aspartylglucosaminuria. Aspartylglucosaminuria is a rare genetic disorder characterized by the accumulation of a substance called aspartylglucosamine in the body. This condition is inherited in an autosomal recessive manner. The NGS (Next-Generation Sequencing) technology used in this genetic test allows for the sequencing of the entire AGA gene, which provides a comprehensive analysis of all the coding regions and intron-exon boundaries. By identifying specific mutations or variations in the AGA gene, this test can help confirm a diagnosis of Aspartylglucosaminuria in individuals suspected of having this condition. The AGA gene NGS genetic test is typically performed on a blood or saliva sample, and the results are interpreted by a qualified geneticist or genetic counselor. A positive result indicating the presence of mutations or variations in the AGA gene confirms the diagnosis of Aspartylglucosaminuria, while a negative result suggests that the individual is unlikely to have this condition. This genetic test is primarily used for diagnostic purposes and can be helpful in guiding treatment decisions and providing genetic counseling to affected individuals and their families. It may also be used for carrier testing in individuals with a family history of Aspartylglucosaminuria or in populations with a higher prevalence of this condition. It is important to note that genetic testing should always be performed and interpreted in conjunction with a comprehensive clinical evaluation and consideration of the individual’s symptoms, family history, and other relevant factors. Genetic counseling is recommended before and after undergoing genetic testing to ensure a thorough understanding of the test results and their implications. |
